Furthermore, Gouva et al. conducted a randomized trial that concluded that early commencement of EPO in non-severe anemia patients who are not yet undergoing dialysis significantly delays CKD progression and prolongs the time before RRT was required [32]. The gene discussed is EPO; the disease is chronic kidney disease.